# AdvanSix Inc.: financial statements, quarterly

ASIX · NYSE · CIK 1673985 · [Materials](/sectors/materials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/asix.md) · [Financials](/companies/asix/financials.md) · [Filings](/companies/asix/filings.md) · [Insiders](/companies/asix/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/asix/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [323](/filings/0001673985-24-000150.md) | [382 d](/filings/0001673985-26-000008.md) | [337](/filings/0001673985-25-000065.md) | [453](/filings/0001673985-25-000119.md) | [398](/filings/0001673985-25-000135.md) | [329 d](/filings/0001673985-26-000008.md) | [378](/filings/0001673985-26-000037.md) | [410](/filings/0001673985-26-000049.md) | [374](/filings/0001673985-25-000135.md) | [360 d](/filings/0001673985-26-000008.md) | [404](/filings/0001673985-26-000037.md) | [421](/filings/0001673985-26-000049.md) |
| Cost of revenue | $m | [315](/filings/0001673985-24-000150.md) | [364 d](/filings/0001673985-26-000008.md) | [334](/filings/0001673985-25-000065.md) | [372](/filings/0001673985-25-000119.md) | [341](/filings/0001673985-25-000135.md) | [318 d](/filings/0001673985-26-000008.md) | [324](/filings/0001673985-26-000037.md) | [351](/filings/0001673985-26-000049.md) | [349](/filings/0001673985-25-000135.md) | [333 d](/filings/0001673985-26-000008.md) | [400](/filings/0001673985-26-000037.md) | [390](/filings/0001673985-26-000049.md) |
| Gross profit | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Selling, general and administrative | $m | [21.6](/filings/0001673985-24-000150.md) | [24.8 d](/filings/0001673985-26-000008.md) | [23.6](/filings/0001673985-25-000065.md) | [24.4](/filings/0001673985-25-000119.md) | [24.3](/filings/0001673985-25-000135.md) | [21.7 d](/filings/0001673985-26-000008.md) | [23.4](/filings/0001673985-26-000037.md) | [25.4](/filings/0001673985-26-000049.md) | [27.4](/filings/0001673985-25-000135.md) | [28.5 d](/filings/0001673985-26-000008.md) | [22.5](/filings/0001673985-26-000037.md) | [22.1](/filings/0001673985-26-000049.md) |
| Income tax | $m | [(2.1)](/filings/0001673985-24-000150.md) | [(3.2) d](/filings/0001673985-26-000008.md) | [(6.0)](/filings/0001673985-25-000065.md) | [13.1](/filings/0001673985-25-000119.md) | [7.5](/filings/0001673985-25-000135.md) | [(13.2) d](/filings/0001673985-26-000008.md) | [5.6](/filings/0001673985-26-000037.md) | [0.3](/filings/0001673985-26-000049.md) | [(0.9)](/filings/0001673985-25-000135.md) | [0.2 d](/filings/0001673985-26-000008.md) | [(5.1)](/filings/0001673985-26-000037.md) | [3.4](/filings/0001673985-26-000049.md) |
| Net income | $m | [(8.0)](/filings/0001673985-24-000150.md) | [(5.1) d](/filings/0001673985-26-000008.md) | [(17.4)](/filings/0001673985-25-000135.md) | [38.9](/filings/0001673985-25-000135.md) | [22.3](/filings/0001673985-25-000135.md) | [0.4 d](/filings/0001673985-26-000008.md) | [23.3](/filings/0001673985-26-000049.md) | [31.4](/filings/0001673985-26-000049.md) | [(2.6)](/filings/0001673985-25-000135.md) | [(2.8) d](/filings/0001673985-26-000008.md) | [(15.5)](/filings/0001673985-26-000049.md) | [3.2](/filings/0001673985-26-000049.md) |
| Diluted EPS | $ per share | [(0.29)](/filings/0001673985-24-000150.md) | not reported | [(0.65)](/filings/0001673985-25-000065.md) | [1.43](/filings/0001673985-25-000119.md) | [0.82](/filings/0001673985-25-000135.md) | not reported | [0.86](/filings/0001673985-26-000037.md) | [1.15](/filings/0001673985-26-000049.md) | [(0.10)](/filings/0001673985-25-000135.md) | not reported | [(0.58)](/filings/0001673985-26-000037.md) | [0.12](/filings/0001673985-26-000049.md) |
| Basic EPS | $ per share | [(0.29)](/filings/0001673985-24-000150.md) | not reported | [(0.65)](/filings/0001673985-25-000065.md) | [1.45](/filings/0001673985-25-000119.md) | [0.83](/filings/0001673985-25-000135.md) | not reported | [0.87](/filings/0001673985-26-000037.md) | [1.17](/filings/0001673985-26-000049.md) | [(0.10)](/filings/0001673985-25-000135.md) | not reported | [(0.58)](/filings/0001673985-26-000037.md) | [0.12](/filings/0001673985-26-000049.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: not reported
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [22.1](/filings/0001673985-23-000142.md) | [29.8](/filings/0001673985-25-000011.md) | [20.6](/filings/0001673985-24-000067.md) | [12.1](/filings/0001673985-24-000107.md) | [17.3](/filings/0001673985-24-000150.md) | [19.6](/filings/0001673985-26-000008.md) | [8.3](/filings/0001673985-25-000065.md) | [18.4](/filings/0001673985-25-000119.md) | [23.7](/filings/0001673985-25-000135.md) | [19.8](/filings/0001673985-26-000049.md) | [17.6](/filings/0001673985-26-000037.md) | [7.2](/filings/0001673985-26-000049.md) |
| Current assets | $m | [414](/filings/0001673985-23-000142.md) | [420](/filings/0001673985-25-000011.md) | [391](/filings/0001673985-24-000067.md) | [379](/filings/0001673985-24-000107.md) | [396](/filings/0001673985-24-000150.md) | [387](/filings/0001673985-26-000008.md) | [418](/filings/0001673985-25-000065.md) | [434](/filings/0001673985-25-000119.md) | [455](/filings/0001673985-25-000135.md) | [441](/filings/0001673985-26-000049.md) | [454](/filings/0001673985-26-000037.md) | [425](/filings/0001673985-26-000049.md) |
| Total assets | $m | [1,476](/filings/0001673985-23-000142.md) | [1,496](/filings/0001673985-25-000011.md) | [1,468](/filings/0001673985-24-000067.md) | [1,478](/filings/0001673985-24-000107.md) | [1,510](/filings/0001673985-24-000150.md) | [1,595](/filings/0001673985-26-000008.md) | [1,626](/filings/0001673985-25-000065.md) | [1,646](/filings/0001673985-25-000119.md) | [1,688](/filings/0001673985-25-000135.md) | [1,706](/filings/0001673985-26-000049.md) | [1,711](/filings/0001673985-26-000037.md) | [1,673](/filings/0001673985-26-000049.md) |
| Current liabilities | $m | [308](/filings/0001673985-23-000142.md) | [359](/filings/0001673985-25-000011.md) | [284](/filings/0001673985-24-000067.md) | [273](/filings/0001673985-24-000107.md) | [295](/filings/0001673985-24-000150.md) | [357](/filings/0001673985-26-000008.md) | [351](/filings/0001673985-25-000065.md) | [321](/filings/0001673985-25-000119.md) | [334](/filings/0001673985-25-000135.md) | [390](/filings/0001673985-26-000049.md) | [370](/filings/0001673985-26-000037.md) | [332](/filings/0001673985-26-000049.md) |
| Total liabilities | $m | [722](/filings/0001673985-23-000142.md) | [757](/filings/0001673985-25-000011.md) | [755](/filings/0001673985-24-000067.md) | [731](/filings/0001673985-24-000107.md) | [744](/filings/0001673985-24-000150.md) | [820](/filings/0001673985-26-000008.md) | [832](/filings/0001673985-25-000065.md) | [823](/filings/0001673985-25-000119.md) | [870](/filings/0001673985-25-000135.md) | [891](/filings/0001673985-26-000049.md) | [914](/filings/0001673985-26-000037.md) | [876](/filings/0001673985-26-000049.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Current portion of debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [754](/filings/0001673985-24-000150.md) | [739](/filings/0001673985-26-000008.md) | [713](/filings/0001673985-25-000135.md) | [747](/filings/0001673985-25-000135.md) | [766](/filings/0001673985-25-000135.md) | [775](/filings/0001673985-26-000049.md) | [794](/filings/0001673985-26-000049.md) | [824](/filings/0001673985-26-000049.md) | [818](/filings/0001673985-25-000135.md) | [815](/filings/0001673985-26-000049.md) | [796](/filings/0001673985-26-000049.md) | [797](/filings/0001673985-26-000049.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: not reported
- Current portion of debt: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [20.8 d](/filings/0001673985-24-000150.md) | [60.2 d](/filings/0001673985-26-000008.md) | [(36.2)](/filings/0001673985-25-000065.md) | [50.2 d](/filings/0001673985-25-000119.md) | [57.3 d](/filings/0001673985-25-000135.md) | [64.2 d](/filings/0001673985-26-000008.md) | [11.4](/filings/0001673985-26-000037.md) | [21.1 d](/filings/0001673985-26-000049.md) | [26.6 d](/filings/0001673985-25-000135.md) | [63.7 d](/filings/0001673985-26-000008.md) | [(15.3)](/filings/0001673985-26-000037.md) | [10.0 d](/filings/0001673985-26-000049.md) |
| Capital expenditure | $m | [25.1 d](/filings/0001673985-24-000150.md) | [38.4 d](/filings/0001673985-26-000008.md) | [35.4](/filings/0001673985-25-000065.md) | [33.5 d](/filings/0001673985-25-000119.md) | [30.5 d](/filings/0001673985-25-000135.md) | [34.3 d](/filings/0001673985-26-000008.md) | [34.1](/filings/0001673985-26-000037.md) | [28.3 d](/filings/0001673985-26-000049.md) | [26.5 d](/filings/0001673985-25-000135.md) | [27.6 d](/filings/0001673985-26-000008.md) | [35.9](/filings/0001673985-26-000037.md) | [20.7 d](/filings/0001673985-26-000049.md) |
| Dividends paid | $m | [4.4 d](/filings/0001673985-24-000150.md) | [4.3 d](/filings/0001673985-26-000008.md) | [4.3](/filings/0001673985-25-000065.md) | [4.3 d](/filings/0001673985-25-000119.md) | [4.3 d](/filings/0001673985-25-000135.md) | [4.3 d](/filings/0001673985-26-000008.md) | [4.3](/filings/0001673985-26-000037.md) | [4.3 d](/filings/0001673985-26-000049.md) | [4.3 d](/filings/0001673985-25-000135.md) | [4.3 d](/filings/0001673985-26-000008.md) | [4.3](/filings/0001673985-26-000037.md) | [4.3 d](/filings/0001673985-26-000049.md) |
| Share repurchases | $m | [9.3 d](/filings/0001673985-24-000150.md) | [8.5 d](/filings/0001673985-26-000008.md) | [7.0](/filings/0001673985-25-000065.md) | [3.4 d](/filings/0001673985-25-000119.md) | [0.0 d](/filings/0001673985-25-000135.md) | [0.0 d](/filings/0001673985-26-000008.md) | [1.5](/filings/0001673985-26-000037.md) | [0.1 d](/filings/0001673985-26-000049.md) | [0.1 d](/filings/0001673985-25-000135.md) | [0.0 d](/filings/0001673985-26-000008.md) | [1.3](/filings/0001673985-26-000037.md) | [0.1 d](/filings/0001673985-26-000049.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [28.9](/filings/0001673985-23-000142.md) | [28.6](/filings/0001673985-24-000067.md) | [28.1](/filings/0001673985-24-000107.md) | [27.2](/filings/0001673985-24-000150.md) | [26.9](/filings/0001673985-25-000065.md) | [27.2](/filings/0001673985-25-000119.md) | [27.2](/filings/0001673985-25-000135.md) | [27.3](/filings/0001673985-26-000037.md) | [27.2](/filings/0001673985-26-000049.md) | [26.9](/filings/0001673985-25-000135.md) | [27.0](/filings/0001673985-26-000037.md) | [27.6](/filings/0001673985-26-000049.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 27,001,186 at 2026-07-31, from the cover of the [10-Q filed 2026-08-07](/filings/0001673985-26-000049.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:45 ET. No prices; not investment advice.